恒敬合创生物医药（浙江）有限公司

恒敬生物根植于公司核心团队20多年的全球研发积累，创建国际领先的生物制药企业，自创成熟、高效、大规模、成本极具竞争力的生物医药产品，产品涵盖胰岛素类药物、GLP-1类药物以及更多的蛋白类、多肽类产品，位于嘉兴的先进工厂一期设计产能3吨原液和过亿支制剂，二期原液产能超10吨。

Virtu Pharmako is a leading biopharmaceutical company with R&D, regulatory submission and CGMP manufacture engaged in four major business areas: Insulin drug portfolio, GLP-1 drug portfolio, biosynthetic technique corporations and varieties of protein/polypeptide bioproducts.

With more than 20 years of global R&D study and commercial experiences, the company established the unique, innovative biotechnology platform which efficiently developed dozens of cost-competitive, environment friendly and commercial-scale biomedical products.

Our state-of-art, world leading biopharmaceutical manufacture facility with building area 1 Million ft2 is built up in Jiaxing, Zhejiang, China, where located in near Metropolitan City, Shanghai. In Phase I, the production capacity includes 3 metric tonnes per year of API and over 120 million units per year of injectable. Production capacity of Phase II will surpasses 10 metric tonnes of API.